Saito S - Search Results

1

Toxicity profile and clinical outcomes of stereotactic body radiotherapy with a focal boost without fiducials or perirectal hydrogel spacer for localized prostate cancer.

Tsurugai Y, Takeda A, Sanuki N, Aoki Y, Kimura Y, Oku Y, Eriguchi T, Yamanaka H, Machida M, Matsushita T, Saito S. Tsurugai Y, et al. Among authors: saito s. Strahlenther Onkol. 2024 Dec 10. doi: 10.1007/s00066-024-02333-4. Online ahead of print. Strahlenther Onkol. 2024. PMID: 39656294

2

Institutional patient accrual volume and the treatment quality of I‑125 prostate seed implantation in a Japanese nationwide prospective cohort study.

Nakamura K, Ohga S, Yorozu A, Saito S, Kikuchi T, Dokiya T, Fukushima M, Yamanaka H. Nakamura K, et al. Among authors: saito s. Strahlenther Onkol. 2019 May;195(5):412-419. doi: 10.1007/s00066-018-1407-y. Epub 2018 Dec 5. Strahlenther Onkol. 2019. PMID: 30519730 English.

3

Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancer.

Ozawa Y, Yagi Y, Nakamura K, Hattori S, Nishiyama T, Momma T, Yorozu A, Saito S. Ozawa Y, et al. Among authors: saito s. Brachytherapy. 2022 Jul-Aug;21(4):451-459. doi: 10.1016/j.brachy.2022.03.001. Epub 2022 Apr 20. Brachytherapy. 2022. PMID: 35461773

4

Biochemical outcomes and toxicities in young men with prostate cancer after permanent iodine-125 seed implantation: Prospective cohort study in 6662 patients.

Katayama N, Yorozu A, Kikuchi T, Higashide S, Masui K, Kojima S, Saito S. Katayama N, et al. Among authors: saito s. Brachytherapy. 2023 May-Jun;22(3):293-303. doi: 10.1016/j.brachy.2022.12.001. Epub 2023 Jan 2. Brachytherapy. 2023. PMID: 36599746

5

Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907).

Yorozu A, Namiki M, Saito S, Egawa S, Yaegashi H, Konaka H, Momma T, Fukagai T, Tanaka N, Ohashi T, Takahashi H, Nakagawa Y, Kikuchi T, Mizokami A, Stone NN. Yorozu A, et al. Among authors: saito s. Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):390-401. doi: 10.1016/j.ijrobp.2023.08.046. Epub 2023 Oct 4. Int J Radiat Oncol Biol Phys. 2024. PMID: 37802225 Clinical Trial.

6

Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapy.

Ozawa Y, Nohara S, Nakamura K, Hattori S, Yagi Y, Nishiyama T, Yorozu A, Monma T, Saito S. Ozawa Y, et al. Among authors: saito s. Prostate. 2024 Apr;84(5):502-510. doi: 10.1002/pros.24668. Epub 2024 Jan 3. Prostate. 2024. PMID: 38173289 Review.

7

Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of ¹²⁵I brachytherapy and robot-assisted radical prostatectomy.

Sutani S, Yorozu A, Toya K, Nishiyama T, Ozu C, Yagi Y, Nakamura K, Saito S. Sutani S, et al. Among authors: saito s. J Contemp Brachytherapy. 2019 Jun;11(3):201-206. doi: 10.5114/jcb.2019.86163. Epub 2019 Jun 28. J Contemp Brachytherapy. 2019. PMID: 31435426 Free PMC article.

8

Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patients.

Yorozu A, Kuroiwa N, Takahashi A, Toya K, Saito S, Nishiyama T, Yagi Y, Tanaka T, Shiraishi Y, Ohashi T. Yorozu A, et al. Among authors: saito s. Brachytherapy. 2015 Mar-Apr;14(2):111-7. doi: 10.1016/j.brachy.2014.06.008. Epub 2014 Aug 7. Brachytherapy. 2015. PMID: 25127123

9

Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.

Shiraishi Y, Yorozu A, Ohashi T, Toya K, Seki S, Yoshida K, Kaneda T, Saito S, Nishiyama T, Hanada T, Shigematsu N. Shiraishi Y, et al. Among authors: saito s. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e127-33. doi: 10.1016/j.ijrobp.2011.01.012. Epub 2011 Mar 11. Int J Radiat Oncol Biol Phys. 2011. PMID: 21398047

10

Japanese clinical practice guidelines for prostate cancer 2023.

Kohjimoto Y, Uemura H, Yoshida M, Hinotsu S, Takahashi S, Takeuchi T, Suzuki K, Shinmoto H, Tamada T, Inoue T, Sugimoto M, Takenaka A, Habuchi T, Ishikawa H, Mizowaki T, Saito S, Miyake H, Matsubara N, Nonomura N, Sakai H, Ito A, Ukimura O, Matsuyama H, Hara I. Kohjimoto Y, et al. Among authors: saito s. Int J Urol. 2024 Nov;31(11):1180-1222. doi: 10.1111/iju.15545. Epub 2024 Jul 30. Int J Urol. 2024. PMID: 39078210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,828 results

Search Page

Filters